HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $838,000 | -57.7% | 146,436 | -32.5% | 0.09% | -44.3% |
| Q4 2021 | $1,982,000 | -22.3% | 217,028 | -9.1% | 0.17% | -25.8% |
| Q3 2021 | $2,552,000 | -32.8% | 238,707 | -2.5% | 0.22% | -32.2% |
| Q2 2021 | $3,800,000 | -12.2% | 244,793 | -8.3% | 0.33% | -17.6% |
| Q1 2021 | $4,327,000 | -23.3% | 266,899 | +0.2% | 0.40% | -18.9% |
| Q4 2020 | $5,639,000 | +14.1% | 266,415 | -20.1% | 0.50% | +29.1% |
| Q3 2020 | $4,943,000 | -6.9% | 333,501 | -7.7% | 0.38% | -13.7% |
| Q2 2020 | $5,312,000 | +17.3% | 361,141 | -6.4% | 0.45% | -3.9% |
| Q1 2020 | $4,528,000 | -19.7% | 385,729 | +60.7% | 0.46% | +12.1% |
| Q4 2019 | $5,640,000 | +14.7% | 240,024 | -9.7% | 0.41% | +11.9% |
| Q3 2019 | $4,917,000 | +143.8% | 265,804 | +145.0% | 0.37% | +166.2% |
| Q2 2019 | $2,017,000 | -37.2% | 108,495 | -17.4% | 0.14% | -31.9% |
| Q1 2019 | $3,210,000 | – | 131,343 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |